|
Goods & Services Limitation Details
|
Description
Class 05 -
Pharmaceutical preparations for use as anti-infectives;
pharmaceutical preparations for the treatment of viral
conditions, namely human immunodeficiency virus (HIV), human
papilloma virus, respiratory syncytial virus, hepatitis,
herpes genitalis, herpes labialis, herpes simplex virus,
varicella-zoster virus, Epstein-Barr virus and
cytomegalovirus; pharmaceutical preparations for the
treatment and prevention of respiratory diseases and
disorders; pharmaceutical preparations for the prevention
and treatment of auto-immune diseases and disorders;
pharmaceutical preparations for the treatment of
atherosclerosis; pharmaceutical preparations for the
treatment and prevention of metabolic related diseases and
disorders namely disorders of the endocrine system, namely
growth and thyroid disorders, diabetes, metabolic syndrome,
obesity, weight loss and weight management; pharmaceutical
preparations for the treatment and prevention of
cardiovascular, pulmonary, cardiorenal and renal diseases
and disorders; pharmaceutical preparations for the
prevention and treatment of oncological diseases and
disorders; pharmaceutical preparations for the treatment of
inflammation and inflammatory related diseases and disorders
namely arthritis, rheumatoid arthritis, inflammatory bowel
diseases, inflammatory connective tissue diseases,
vasculitis, synovitis; pharmaceutical preparations for the
treatment of blood diseases and disorders namely
thrombocytopenia, coagulation disorders, bleeding disorders,
platelet disorders, blood vessel disorders, sickle cell
disease, anaemia, sepsis and infections in and of the blood;
pharmaceutical preparations for the treatment of
musculoskeletal diseases; pharmaceutical preparations for
the treatment of connective tissue diseases, bone diseases,
osteoporosis, spinal diseases, back pain, gout, fractures,
sprains, osteogenesis imperfecta, muscle wasting (cachexia),
renal osteodystrophy, cartilage injuries, ligament injuries,
joint replacement and osteoarthritis; pharmaceutical
preparations for use in ophthalmology; pharmaceutical
preparations for the treatment of dermatological diseases
and disorders namely dermatitis, skin infections namely
acne, bacterial skin infections, fungal skin infections,
viral skin infections and parasitic skin infections,
psoriasis, eczema; pharmaceutical preparations for the
treatment of hormonal disorders; pharmaceutical preparations
for the treatment of gastrointestinal diseases and
disorders; pharmaceutical preparations for the treatment of
irritable bowel disorders and symptoms, digestive disorders;
pharmaceutical preparations for the treatment of
gynaecological diseases and disorders namely amenorrhoea,
dysmenorrhea and infertility; pharmaceutical hormonal
preparations namely corticosteroids, hormone replacement
therapy preparations, oral contraceptives, thyroid hormone
preparations; pharmaceutical preparations for the treatment
of incontinence, prostate diseases and disorders, bladder
diseases and disorders; pharmaceutical preparations for the
treatment of inflammatory pelvic diseases, vasomotor
symptoms, menopausal symptoms, endometriosis, uterine
fibroids and Leiomyoma; pharmaceutical preparations and
substances for use in urology, pre-eclampsia and pre-term
labour; pharmaceutical preparations for the treatment of
genitourinary diseases, namely, urological diseases,
infertility, sexually transmitted diseases; pharmaceutical
preparations for the treatment of hepatological diseases and
disorders; pharmaceutical preparations for the treatment of
hepatitis, non-alcoholic fatty liver disease (NAFLD),
non-alcoholic steatohepatitis (NASH), liver fibroids,
cirrhosis, cholestatic pruritus and primary biliary
cholangitis; pharmaceutical preparations for the treatment
of alopecia and androgenic alopecia; pharmaceutical
preparations for the treatment of psychiatric diseases and
disorders namely mood disorders, anxiety disorders,
cognitive disorders, schizophrenia and psychoses;
pharmaceutical preparations for the treatment of malaria;
pharmaceutical preparations for the treatment of
tuberculosis; allergy medications; vaccines for human use;
pharmaceutical preparations for the treatment of central
nervous system and neurological diseases and disorders
namely Parkinsons Disease, Alzheimers Disease, Huntingtons
Disease, dementia, migraine, cerebral palsy, brain injury,
spinal cord injury, seizure disorders, epilepsy, restless
legs syndrome, pain, neuropathic pain, inflammatory pain,
fibromyalgia, stroke, multiple sclerosis, insomnia;
pharmaceutical preparations for the treatment of muscular
dystrophy; pharmaceutical preparations and substances for
the prevention, treatment and alleviation of nephrological
related diseases and disorders.
|